NCT05096780View on ClinicalTrials.gov

Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage and Associated Mood and Physiological Effects

PHASE1CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

February 6, 2022

Study Completion Date

February 6, 2022

Conditions

Alertness

Interventions

OTHER

Flavored caffeinated beverage

16.9 oz (500 cc), carbonated, zero calorie

Trial Locations (1)

56529

AXIS Clinicals, Dilworth

All Listed Sponsors

lead

PepsiCo Global R&D

INDUSTRY